Perceptive Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Hold |
0
| – | – | – | 98 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 88 |
|
|
2023
Q1 | – | Sell |
-341,239
| Closed | -$5.37M | – | 100 |
|
|
2022
Q4 | $5.37M | Hold |
341,239
| – | – | 0.15% | 69 |
|
|
2022
Q3 | $5.37M | Hold |
341,239
| – | – | 0.16% | 78 |
|
|
2022
Q2 | $4.76M | Sell |
341,239
-42,000
| -11% | -$586K | 0.15% | 79 |
|
|
2022
Q1 | $6.61M | Sell |
383,239
-397,997
| -51% | -$6.86M | 0.13% | 95 |
|
|
2021
Q4 | $11.4M | Hold |
781,236
| – | – | 0.18% | 84 |
|
|
2021
Q3 | $14.1M | Sell |
781,236
-68,764
| -8% | -$1.24M | 0.2% | 84 |
|
|
2021
Q2 | $14.9M | Buy |
850,000
+200,000
| +31% | +$3.51M | 0.19% | 94 |
|
|
2021
Q1 | $16.4M | Buy |
+650,000
| New | +$16.4M | 0.21% | 84 |
|
|
2017
Q2 | – | Sell |
-1,260,847
| Closed | -$37.6M | – | 124 |
|
|
2017
Q1 | $37.6M | Hold |
1,260,847
| – | – | 2.14% | 11 |
|
|
2016
Q4 | $34.2M | Buy |
1,260,847
+830,847
| +193% | +$22.5M | 2.43% | 11 |
|
|
2016
Q3 | $11M | Buy |
+430,000
| New | +$11M | 0.71% | 36 |
|